Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Colorectal Neoplasms 491Rectal Neoplasms 267Colonic Neoplasms 218Pancreatic Neoplasms 186Stomach Neoplasms 181Esophageal Neoplasms 134Breast Neoplasms 118Neoplasm Metastasis 116Squamous Cell Carcinoma of Head and Neck 94Head and Neck Neoplasms 92Neoplasms 88Adenocarcinoma Of Esophagus 67Esophageal Squamous Cell Carcinoma 61Carcinoma, Hepatocellular 54Adenocarcinoma 40Nasopharyngeal Carcinoma 33Cholangiocarcinoma 32Biliary Tract Neoplasms 26Anus Neoplasms 26Gastrointestinal Neoplasms 25Carcinoma, Squamous Cell 25Carcinoma, Non-Small-Cell Lung 25Keratosis, Actinic 22Gallbladder Neoplasms 21Urinary Bladder Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 20Liver Neoplasms 20Bile Duct Neoplasms 19Ovarian Neoplasms 16Carcinoma 16

Interventions

Cisplatin 13Cetuximab 10Radiotherapy 7pembrolizumab 4Pemetrexed 4Fluorouracil 4Docetaxel 4Gemcitabine 3durvalumab 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Narrow Band Imaging 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gefitinib 2Drug Therapy 2Carboplatin 2tremelimumab 1niraparib 1monalizumab 1linrodostat 1dostarlimab 1capmatinib 1X-Rays 1Vitamin B 12 1Tirapazamine 1Tablets 1Sugars 1Radiotherapy, Adjuvant 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Laryngeal Diseases × Fluorouracil × Clear all
NCT07419464 2026-04-27

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

Washington University School of Medicine

Phase 2 Recruiting
46 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

NCT03340896 2025-09-02

SALTORL

Groupe Oncologie Radiotherapie Tete et Cou

Phase 3 Active not recruiting
256 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

NCT01693718 2024-01-29

A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

University of Chicago

Phase 2 Completed
44 enrolled
Head & Neck

Laryngeal Diseases, Neoplasms

NCT01884259 2022-05-26

HNO-2

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 2 Completed
100 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡